Ownership history in Core Alternative Capital · 16 quarters on record
This page tracks every 13F SEC filing in which Core Alternative Capital reported a position in WEST PHARMACEUTICAL SERVICES (WST). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 3 | — | 0% | 0.00% | $787 | $261.88 |
| 2025 Q2 | UNCHANGED | 3 | — | 0% | 0.00% | $656 | $218.25 |
| 2025 Q1 | UNCHANGED | 3 | — | 0% | 0.00% | $672 | $223.09 |
| 2024 Q4 | UNCHANGED | 3 | — | 0% | 0.00% | $983 | $326.20 |
| 2024 Q3 | UNCHANGED | 3 | — | 0% | 0.00% | $900 | $298.72 |
| 2024 Q2 | UNCHANGED | 3 | — | 0% | 0.00% | $988 | $327.59 |
| 2024 Q1 | REDUCED | 3 | -19 | -86.4% | 0.00% | $1K | $393.34 |
| 2023 Q4 | REDUCED | 22 | -1 | -4.3% | 0.00% | $8K | $349.82 |
| 2023 Q3 | UNCHANGED | 23 | — | 0% | 0.00% | $9K | $372.54 |
| 2023 Q2 | ADDED | 23 | +1 | +4.5% | 0.00% | $9K | $379.56 |
As of 2025 Q4 — sorted by position size